Our portfolio of products contains new innovative crop-derived Health Ingredients from sustainable sources.
All our ingredients undergo clinical trials to demonstrate their efficacy in improving human health and are fully protected by a broad intellectual property portfolio of patents.
Our most advanced product, Xtramune™ is a unique proprietary carrot-derived fibre under development to support immune function and improve resistance to respiratory infections.
Xtramune™ is being developed as a natural food ingredient. We have obtained proof of concept in humans and positive results from a clinical efficacy trial involving a challenge with a common cold virus. The ingredient is currently tested further in a third clinical trial in subjects with increased susceptibility to respiratory tract infections. In total more than 800 subjects have participated in the research program.
Xtramune™ is expected to be ready for formulation in dietary supplements in 2020, followed by medical food and functional foods later on.
NL-02 is an innovative crop-derived food ingredient under development to improve gut health of consumers and patients. NL-02 is in pre-clinical stage.
NL-03 is our third lead, under development to improve metabolic health through gut microbiome modulation and is currently in the discovery stage.